Low Dose Carbon Monoxide Exposure in Idiopathic Pulmonary Fibrosis Produces a CO Signature Comprised of Oxidative Phosphorylation Genes

Compelling preclinical studies indicate that low-dose carbon monoxide (CO) abrogates experimental lung fibrosis. We recently reported the results of a multicenter, double-blinded, clinical trial of inhaled CO in patients with idiopathic pulmonary fibrosis (IPF). Identifying no significantly changes...

Descripción completa

Detalles Bibliográficos
Autores principales: Casanova, Nancy, Zhou, Tong, Gonzalez-Garay, Manuel L., Rosas, Ivan O., Goldberg, Hilary J., Ryter, Stefan W., Collard, Harold R., El-Chemaly, Souheil, Flaherty, Kevin R., Hunninghake, Gary M., Lasky, Joseph A., Lederer, David J., Machado, Roberto F., Martinez, Fernando J., Noth, Imre, Raghu, Ganesh, Choi, Augustine M. K., Garcia, Joe G. N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794274/
https://www.ncbi.nlm.nih.gov/pubmed/31615996
http://dx.doi.org/10.1038/s41598-019-50585-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794274/
https://www.ncbi.nlm.nih.gov/pubmed/31615996
http://dx.doi.org/10.1038/s41598-019-50585-3

Ejemplares similares